We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Abcann Global Corporation | TSXV:ABCN | TSX Venture | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0 | - |
From Jul 2019 to Jul 2024
TORONTO, Aug. 23, 2017 /CNW/ - Ken Clement, Founder and Executive Chair and Aaron Keay, CEO, ABcann Global Corporation (ABCN), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange to open the market. ABcann Global is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). ABcann's flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. ABcann Global Corporation commenced trading on TSX Venture Exchange on May 4, 2017.
SOURCE TMX Group Limited
Copyright 2017 Canada NewsWire
1 Year Abcann Global Corporation Chart |
1 Month Abcann Global Corporation Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
